Navigation Links
US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
Date:6/19/2012

(PRWEB) June 19, 2012

The US Drug Watchdog says, "We do not want recipients of the now recalled DePuy ASR metal on metal hip implant, to walk away from their rights, or get much less than they deserve. Please call us at 866-714-6466, so that we can get you to actual legal experts, that will protect your rights, if you are a recipient of a now recalled DePuy ASR hip implant, and or if you if you received a letter from Broadspire related to the now recalled DePuy ASR hip implant. Do not accept anything less than the best possible deal for yourself." According to Reuters, on August 21st 2011, "In a highly unusual move, DePuy has hired a third party -- Broadspire Services Inc, which manages workers compensation and other medical claims on behalf of insurance companies and employers -- to administer patient claims for out-of-pocket medical costs associated with the recall." The US Drug Watchdog is urging any recipient of the now recalled DePuy ASR metal on metal hip implant who have received a letter from a company called Broadspire, to get legal advice before signing anything, and the group is offering the names, and specific contacts of skilled attorneys, that are very knowledgeable about the recalled DePuy ASR metal on metal hip implant. http://USDrugWatchdog.Com

Urgent Notice From The US Drug Watchdog: "We have just learned there may be a cut off date of August 2012 to get all individuals, who are recipients of the now recalled DePuy ASR hip implant identified to the federal court in Ohio, and we can help recommend attorneys to expedite this process. For more information hip implant recipients of a now Recalled DePuy ASR can call us anytime at 866-714-6466, and we do not care if the hip implant device has failed yet, or not." http://USDrugWatchdog.Com

The US Drug Watchdog indicates symptoms of the recalled DePuy ASR hip implant failure include:

  • Pain in the Hip Region
  • Problems While Walking or The Inability to Walk
  • Swelling of the Hip
  • General Discomfort
  • Lack of Flexibility
  • Elevated levels of cobalt in a recipients blood stream

The US Drug Watchdog is the premier medical device, and pharmaceutical watchdog in the United States. The group says, "We want to make certain all DePuy ASR hip implant recipients get to national caliber trial law firms or attorneys, that have the best record in achieving superior results for their clients, with the emphasis being compensation." For more information please contact the US Drug Watchdog anytime at 866-714-6466, or contact the group via its web site at http://USDrugWatchdog.Com

Ohio Southern Federal District Court Case Number MDL No. 2197

Read the full story at http://www.prweb.com/releases/2012/6/prweb9608571.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related medicine news :

1. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
2. US Drug Watchdog Now Urges All Recalled DePuy ASR Hip Implant Recipients Call Them For The Names Of The Best Attorneys Out Of Fear The Recipients Will Get Nothing
3. SYNERGY HomeCare Offers Free Home Safety Assessments
4. New molecular structure offers first picture of a protein family vital to human health
5. Skin transplant offers new hope for vitiligo patients
6. Study Offers Ways to Decrease Use of Restraints at Nursing Homes
7. Prosthetic retina offers simple solution to restoring sight
8. Botox Offers Little Relief for Migraine, Study Finds
9. Wilderness Medicine founder offers health tips for summer season
10. Mayo Clinic offers newly approved treatment for acid reflux disease
11. Landmark textbook on health care and the US legal system released
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
(Date:12/8/2016)... ... , ... David J. Dykeman , Ginger Pigott , and ... at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg ... global Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... 10.2 version gives development continuity to its innovative Unified Instance Manager architecture, ... capacity. In addition, this new version optimizes the unattended auto-dialing system without ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to ... convenient service for Texas, they are expanding their presence in Dallas. One of the ... that will bring new jobs to the Dallas and Forth Worth market. STAT takes ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and the Affordable Care Act. Dr. Botelho advocates for the mass media launching ... movement gives people ongoing opportunities to share their unfortunate experiences; such a movement ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... from offices headquartered in Hamilton County, is embarking on a charity drive with ... in finding new homes for orphaned or neglected senior dogs in the Cincinnati ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 Australia Glaucoma Surgery Devices ... new report, "Australia Glaucoma Surgery Devices Market Outlook ... Australia Glaucoma Surgery Devices market. The report provides ... units) and average prices (USD) within market segement ... provides company shares and distribution shares data for ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... to grow in 2017-2023. Various reasons for growth of ... population, higher incidences of chronic diseases, high recovery cost ... aid services. Medical lifting sling refers to an ... limited mobility. These slings connect to the lift and ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology: